Copyright
©The Author(s) 2018.
World J Clin Cases. Dec 6, 2018; 6(15): 961-984
Published online Dec 6, 2018. doi: 10.12998/wjcc.v6.i15.961
Published online Dec 6, 2018. doi: 10.12998/wjcc.v6.i15.961
Figure 4 Funnel plot showing the relationship between the relative risk and its standard error for each of 45 studies used in a fixed effects meta-analysis with a moderator for concomitant drug therapy evaluating the effect of Medilac-S® in combination with conventional drug therapy on clinical efficacy.
- Citation: Sohail G, Xu X, Christman MC, Tompkins TA. Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis. World J Clin Cases 2018; 6(15): 961-984
- URL: https://www.wjgnet.com/2307-8960/full/v6/i15/961.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i15.961